chr20-58389302-A-AC
Position:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1
The NM_004738.5(VAPB):c.-149dup variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0943 in 395,364 control chromosomes in the GnomAD database, including 2,062 homozygotes. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.15 ( 1920 hom., cov: 27)
Exomes 𝑓: 0.067 ( 142 hom. )
Consequence
VAPB
NM_004738.5 5_prime_UTR
NM_004738.5 5_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.452
Genes affected
VAPB (HGNC:12649): (VAMP associated protein B and C) The protein encoded by this gene is a type IV membrane protein found in plasma and intracellular vesicle membranes. The encoded protein is found as a homodimer and as a heterodimer with VAPA. This protein also can interact with VAMP1 and VAMP2 and may be involved in vesicle trafficking. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP6
Variant 20-58389302-A-AC is Benign according to our data. Variant chr20-58389302-A-AC is described in ClinVar as [Likely_benign]. Clinvar id is 338925.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.294 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
VAPB | NM_004738.5 | c.-149dup | 5_prime_UTR_variant | 1/6 | ENST00000475243.6 | NP_004729.1 | ||
VAPB | NM_001195677.2 | c.-149dup | 5_prime_UTR_variant | 1/3 | NP_001182606.1 | |||
VAPB | NR_036633.2 | n.83dup | non_coding_transcript_exon_variant | 1/4 | ||||
VAPB | XR_001754433.3 | n.83dup | non_coding_transcript_exon_variant | 1/6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
VAPB | ENST00000475243.6 | c.-149dup | 5_prime_UTR_variant | 1/6 | 1 | NM_004738.5 | ENSP00000417175 | P1 | ||
VAPB | ENST00000395802.7 | upstream_gene_variant | 1 | ENSP00000379147 |
Frequencies
GnomAD3 genomes AF: 0.151 AC: 19399AN: 128310Hom.: 1919 Cov.: 27
GnomAD3 genomes
AF:
AC:
19399
AN:
128310
Hom.:
Cov.:
27
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0601 AC: 4078AN: 67844Hom.: 47 AF XY: 0.0613 AC XY: 2317AN XY: 37796
GnomAD3 exomes
AF:
AC:
4078
AN:
67844
Hom.:
AF XY:
AC XY:
2317
AN XY:
37796
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0669 AC: 17869AN: 266966Hom.: 142 Cov.: 5 AF XY: 0.0681 AC XY: 10352AN XY: 151902
GnomAD4 exome
AF:
AC:
17869
AN:
266966
Hom.:
Cov.:
5
AF XY:
AC XY:
10352
AN XY:
151902
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.151 AC: 19413AN: 128398Hom.: 1920 Cov.: 27 AF XY: 0.148 AC XY: 9151AN XY: 61718
GnomAD4 genome
AF:
AC:
19413
AN:
128398
Hom.:
Cov.:
27
AF XY:
AC XY:
9151
AN XY:
61718
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Amyotrophic Lateral Sclerosis, Dominant Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Dec 29, 2019 | - - |
Spinal Muscular Atrophy, Dominant Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at